13 of the 20 best-selling drugs in the U.S. with possible drug safety risk due to lack of FDA oversight and inspection of manufacturing facilities in Puerto Rico.
1. Lipitor (Pfizer) for high cholesterol
2. Zocor (Merck) for high cholesterol
3. Plavix (BMS Sanofi) a blood thinner
4. Aranesp (Amgen) anemia
5. Zoloft (Pfizer) for depression
6. Epogen (Amgen) for anemia
7. Enbrel (Amgen) for rheumatoid arthritis
8. Procrit (Ortho Biotech) for anemia
9. Norvasc (Pfizer) for high blood pressure
10. Neulasta (Amgen) for low white blood cells in chemotherapy
11. Effexor XR (Wyeth) for depression
12. Zyprexa (Eli Lilly) for schizophrenia, bipolar disorder
13. Risperdal (Janssen) for schizophrenia, bipolar disorder
Filed under: health, mental health | Tagged: drug safety, effexor, manufacturing, Puerto Rico, risperdal
